Prostaglandin E3 (PGE3) is primarily studied for its anti-inflammatory and anti-proliferative properties. It has shown potential in reducing inflammation in various conditions, making it a candidate for treating inflammatory diseases such as arthritis. Additionally, PGE3 is being researched for its role in cancer prevention, as it may inhibit the growth of certain cancer cells, particularly in colon and breast cancer. It is also explored for its cardiovascular benefits, including its ability to reduce blood pressure and prevent blood clot formation. In dermatology, PGE3 is investigated for its potential to promote skin healing and reduce scarring. Its applications in medical research continue to expand as its mechanisms and effects are further understood.